These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22069723)

  • 41. Phosphorylation of 3-deazaguanosine by nicotinamide riboside kinase in Chinese hamster ovary cells.
    Saunders PP; Tan MT; Spindler CD; Robins RK
    Cancer Res; 1989 Dec; 49(23):6593-9. PubMed ID: 2555047
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tiazofurin is phosphorylated by three enzymes from Chinese hamster ovary cells.
    Saunders PP; Spindler CD; Tan MT; Alvarez E; Robins RK
    Cancer Res; 1990 Sep; 50(17):5269-74. PubMed ID: 2143686
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nicotinamide riboside kinase structures reveal new pathways to NAD+.
    Tempel W; Rabeh WM; Bogan KL; Belenky P; Wojcik M; Seidle HF; Nedyalkova L; Yang T; Sauve AA; Park HW; Brenner C
    PLoS Biol; 2007 Oct; 5(10):e263. PubMed ID: 17914902
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mycophenolate mofetil, an inhibitor of inosine monophosphate dehydrogenase, causes a paradoxical elevation of GTP in erythrocytes of renal transplant patients.
    Goldsmith D; Carrey EA; Edbury S; Smolenski RT; Jagodzinski P; Simmonds HA
    Clin Sci (Lond); 2004 Jul; 107(1):63-8. PubMed ID: 14723604
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk.
    Ferrell M; Wang Z; Anderson JT; Li XS; Witkowski M; DiDonato JA; Hilser JR; Hartiala JA; Haghikia A; Cajka T; Fiehn O; Sangwan N; Demuth I; König M; Steinhagen-Thiessen E; Landmesser U; Tang WHW; Allayee H; Hazen SL
    Nat Med; 2024 Feb; 30(2):424-434. PubMed ID: 38374343
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Accumulation of the endogenous L-arginine analogue NG-monomethyl-L-arginine in human end-stage renal failure patients on regular haemodialysis.
    Mendes Ribeiro AC; Roberts NB; Lane C; Yaqoob M; Ellory JC
    Exp Physiol; 1996 May; 81(3):475-81. PubMed ID: 8737080
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of Isn1 and Sdt1 as glucose- and vitamin-regulated nicotinamide mononucleotide and nicotinic acid mononucleotide [corrected] 5'-nucleotidases responsible for production of nicotinamide riboside and nicotinic acid riboside.
    Bogan KL; Evans C; Belenky P; Song P; Burant CF; Kennedy R; Brenner C
    J Biol Chem; 2009 Dec; 284(50):34861-9. PubMed ID: 19846558
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of 1-methylnicotinamide and its metabolite N-methyl-2-pyridone-5-carboxamide on streptozotocin-induced toxicity in murine insulinoma MIN6 cell line.
    Przygodzki T; Slominska E; Polakowska E; Mlynarski W; Watala C
    Acta Biochim Pol; 2011; 58(1):75-7. PubMed ID: 21403919
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nicotinamide riboside supplementation dysregulates redox and energy metabolism in rats: Implications for exercise performance.
    Kourtzidis IA; Dolopikou CF; Tsiftsis AN; Margaritelis NV; Theodorou AA; Zervos IA; Tsantarliotou MP; Veskoukis AS; Vrabas IS; Paschalis V; Kyparos A; Nikolaidis MG
    Exp Physiol; 2018 Oct; 103(10):1357-1366. PubMed ID: 30007015
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolic studies on red cells from patients with chronic renal disease on haemodialysis.
    Wallas CH
    Br J Haematol; 1974 Jan; 26(1):71-8. PubMed ID: 4853177
    [No Abstract]   [Full Text] [Related]  

  • 51. Characterization of uraemia-induced decrease in insulin binding on erythrocytes.
    Marttinen A; Pasternack A; Koivula T
    Nephrol Dial Transplant; 1987; 2(4):233-7. PubMed ID: 3118263
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nicotinamide riboside does not alter mitochondrial respiration, content or morphology in skeletal muscle from obese and insulin-resistant men.
    Dollerup OL; Chubanava S; Agerholm M; Søndergård SD; Altıntaş A; Møller AB; Høyer KF; Ringgaard S; Stødkilde-Jørgensen H; Lavery GG; Barrès R; Larsen S; Prats C; Jessen N; Treebak JT
    J Physiol; 2020 Feb; 598(4):731-754. PubMed ID: 31710095
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heme biosynthesis in uremic patients on CAPD or hemodialysis.
    Fontanellas A; Coronel F; Santos JL; Herrero JA; Moran MJ; Guerra P; Tornero F; de Salamanca RE
    Kidney Int; 1994 Jan; 45(1):220-3. PubMed ID: 8127011
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies on the mechanism of action of benzamide riboside: a novel inhibitor of IMP dehydrogenase.
    Gharehbaghi K; Grünberger W; Jayaram HN
    Curr Med Chem; 2002 Apr; 9(7):743-8. PubMed ID: 11966437
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metabolite profiling identifies markers of uremia.
    Rhee EP; Souza A; Farrell L; Pollak MR; Lewis GD; Steele DJ; Thadhani R; Clish CB; Greka A; Gerszten RE
    J Am Soc Nephrol; 2010 Jun; 21(6):1041-1051. PubMed ID: 20378825
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Orotidine accumulation in human erythrocytes during allopurinol therapy: association with high urinary oxypurinol-7-riboside concentrations in renal failure and in the Lesch-Nyhan syndrome.
    Simmonds HA; Reiter S; Davies PM; Cameron JS
    Clin Sci (Lond); 1991 Mar; 80(3):191-7. PubMed ID: 1850677
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Superoxide anion generation, erythrocytes superoxide dismutase activity, and lipid peroxidation during hemoperfusion and hemodialysis in chronic uremic patients.
    Trznadel K; Pawlicki L; Kedziora J; Luciak M; Błaszczyk J; Buczyński A
    Free Radic Biol Med; 1989; 6(4):393-7. PubMed ID: 2540072
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Liquid-chromatographic determination of guanidino compounds in plasma and erythrocyte of normal persons and uremic patients.
    Kikuchi T; Orita Y; Ando A; Mikami H; Fujii M; Okada A; Abe H
    Clin Chem; 1981 Nov; 27(11):1899-902. PubMed ID: 7296840
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targets and markers of selective action of tiazofurin.
    Weber G; Natsumeda Y; Pillwein K
    Adv Enzyme Regul; 1985; 24():45-65. PubMed ID: 2424286
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IMP dehydrogenase: inhibition by the anti-leukemic drug, tiazofurin.
    Yamada Y; Natsumeda Y; Yamaji Y; Jayaram HN; Tricot GJ; Hoffman R; Weber G
    Leuk Res; 1989; 13(2):179-84. PubMed ID: 2564451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.